Napo announced today the appointment of Darlene Horton, M.D., a biopharmaceutical veteran and leading clinical development expert, to the role of Chief Medical Officer (CMO) for Napo.
RedHill Biopharma Ltd., a speciality company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal (GI) diseases...